MafB, a transcription factor expressed selectively in macrophages, has important roles in some macrophage-related diseases, especially in atherosclerosis. In this study, we investigated the mechanism by which hematopoietic-specific MafB deficiency induces the development of obesity. Wild-type and hematopoietic cell-specific Mafb-deficient mice were fed a high-fat diet for 10 weeks. The Mafb-deficient mice exhibited higher body weights and faster rates of body weight increase than control mice. The Mafb-deficient mice also had a higher percentage of body fat than the wild-type mice, due to increased adipocyte size and serum cholesterol levels. Reverse transcription-PCR analysis showed a reduction in apoptosis inhibitor of macrophage (AIM) in Mafb-deficient adipose tissue. AIM is known as an inhibitor of lipogenesis in adipocytes and is expressed in adipose tissue macrophages. Collectively, our data suggest that Mafb deficiency in hematopoietic cells accelerates the development of obesity.
MafB, also known as v-maf musculoaponeurotic fibrosarcoma oncogene homolog B, belongs to the large Maf transcription factor family, the members of which contain basic leucine zipper (bZIP) domains that bind to DNA. These bZIP domains are located within the Maf recognition element (MARE) and regulate the transcription of target genes by binding to acidic domains within the genes [1] . MafB plays various roles in a variety of differentiation processes, including the differentiation of pancreatic a and b cells, podocytes in the renal glomerulus, and rhombomeres (r5) in the embryonic hindbrain. MafB is also central to embryonic thymus development, parathyroid gland development, the creation of hair cuticles, and urethral masculinization [2] [3] [4] [5] [6] [7] . In the hematopoietic system, MafB is important for myeloid lineage commitment of hematopoietic stem cells and for macrophage differentiation [5, 8] . Recently, we reported that MafB expression is induced by liver X receptor (LXR), which is activated by oxidized low-density lipoprotein (LDL) and regulates apoptosis inhibitor of macrophage (AIM, also called Api6/Spa/CD5L). Consistently, MafB deficiency has been shown to ameliorate atherosclerotic lesions due to increased apoptosis of foam cells [9] .
Apoptosis inhibitor of macrophage, a member of the scavenger receptor cysteine-rich superfamily, is a soluble protein mainly expressed in macrophages. AIM has multiple functions, including inhibiting the induction of apoptosis, inducing the coagulation of certain types of bacteria, and preventing the development of autoimmunity by binding to IgM [10] [11] [12] [13] [14] . AIM expression in adipose tissue macrophages (ATMs) plays a role in adipocyte lipolysis. AIM is incorporated into adipocytes via CD36 scavenger receptor-mediated endocytosis. Following this, AIM binds to fatty acid synthase (FASN), thereby inhibiting its activity [15, 16] . AIM-deficient mice develop obesity and increase adipose tissue mass [16] . Although MafB regulates AIM in foam cells within atherosclerotic lesions, it is unknown whether MafB also regulates AIM in ATMs.
In this study, we investigated the relationship between MafB and obesity using the following two approaches: (1) we reconstituted hematopoietic systems in mice via transplantation of Mafb À/À fetal liver cells and fed these mice a high-fat diet (HFD), and (2) we fed a HFD to hematopoietic cell-specific Mafb-deficient mice (Mafb 
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Mice
Mafb
À/À mice were generated in a 129/Sv background and backcrossed to the C57BL/6J strain for over seven generations [5] . The primer sequences used for genotyping were described in previous studies [5] . For hematopoietic system reconstitution, fetal liver cells were isolated from either E14. ::Tie2-Cre mice). To induce obesity, the mice were fed a HFD for 10 weeks. Each week, the body weight of mice and their food consumption were measured. The mice were maintained under specific pathogen-free conditions in a laboratory animal resource center at the University of Tsukuba. All experiments were performed according to the Guide for the Care and Use of Laboratory Animals of University of Tsukuba.
Computed tomography scanning
To evaluate the body fat percentage in mice, we performed computed tomography (CT) scanning. Mice were anesthetized via intraperitoneal injection of a mixture of medetomidine (0.3 mgÁkg À1 ; Zenoaq, Fukushima, Japan), midazolam (4 mgÁkg À1 ; Astellas, Tokyo, Japan), and butorphanol (5 mgÁkg À1 ; Meiji Seika Pharma, Tokyo, Japan).
Following this, their body fat percentage was measured using an Aloka LCT-100A CT Scanner.
Serum cholesterol measurement
To collect serum, whole blood was collected and stored at room temperature for 30 min. Following this, the blood was centrifuged for 30 min at 2000 g at 4°C, and the separated serum was transferred into new tubes. Cholesterol levels were measured using an Automated Clinical Chemistry Analyzer (DRI-CHEM 7000V; Fujifilm, Tokyo, Japan).
Histological analysis
In this study, we utilized male mice for the hematopoietic system reconstitution and female mice for conditional KO. Epidermal fat pads were collected from wild-type and Mafb À/À mice, and inguinal and ovary fat pads were collected from Mafb f/f and Mafb f/f ::Tie2-Cre mice. The collected fat pads were either fixed in 4% paraformaldehyde solution and embedded in optimum cutting temperature compound or fixed in neutral-buffered formalin and embedded in paraffin. Paraffin sections were stained with hematoxylin and eosin (HE), and adipocyte size was measured using IMAGEJ analysis software (NIH, Bethesda, MD, USA). The frozen sections were incubated with rabbit anti-GFP (MBL, Woburn, MA, USA), rabbit anti-(mouse MafB) (Bethyl, Montgomery, TX, USA) and rat anti-(mouse Mac-2) (Cedarlane, Burlington, NC, USA). Alexa Fluor 488-conjugated goat anti-(rabbit IgG) (Molecular Probes, Eugene, OR, USA) and Cy3-conjugated donkey anti-(rat IgG) (Jackson ImmunoResearch, West Grove, PA, USA) were used as secondary antibodies. Hoechst 33342 (Thermofisher, Rockford, IL, USA) was used to stain nuclei.
Quantitative RT-PCR analysis
Adipose tissue was collected and incubated with 0.5% collagenase A (Roche, Mannheim, Germany) for 1 h at 37°C. The digested adipose tissue was filtered through a 70-lm strainer and centrifuged at 300 g for 4 min at 4°C. The cell pellet was collected and washed with phosphate-buffered saline. Total RNA was collected using an Isogen kit (Nippon gene, 311-02501). cDNA was synthesized using a QuantiTect Reverse Transcription Kit (Qiagen Valencia, CA, USA). The mRNA levels of Mafb, AIM, and Mac-1 were measured using SYBR green PCR master mix (Takara Bio, Otsu, Japan). The mRNA levels of Mafb and AIM were normalized to the Mac-1 mRNA level. The following primer sequences were used: Mafb forward, 5
0 -TGAATTTGCTG
Statistical analysis
All data are shown as the mean AE SEM. P-values were calculated using two-tailed Student's t-tests.
Results
MafB affects body weight in mice
Because Mafb deficiency strongly reduced the expression of AIM both in foam cell within atherogenic lesion and in vitro macrophages [9] . A Recent report identified that AIM-deficient mice developed obesity, because AIM inhibited adipose tissue mass in high-fat diet (HFD) condition [16] . As this paper showed that the cells that express AIM were adipose tissue macrophages, we hypothesized that MafB is also expressed in adipose tissue macrophages and inhibits adipose tissue mass through regulation of AIM expression. To address this hypothesis, first we examined the effects of MafB on mouse body weight in HFD condition. Because Mafb-deficient mice die after birth [5] , we transplanted fetal liver cells from wild-type and Mafb À/À E14.5 embryos into X-ray-irradiated recipient mice to generate wild-type and Mafb À/À hematopoietic system-reconstituted mice. Following this, the mice were fed a HFD for 10 weeks, and their body weights were measured. After 9 weeks, the Mafb À/À mice had significantly higher body weights compared to the wild-type mice (Fig. 1A) . The body weights of the Mafb À/À mice also increased at a higher rate than those of the wild-type mice (Fig. 1B) . In addition, we also generated Mafb conditional KO mice, Mafb f/f :: Tie2-Cre mice, that Mafb expression was specifically lacked in hematopoietic stem cells and macrophages [17] [18] [19] . After feeding these mice a HFD for 6 weeks, their body weights and rates of body weight increase were both higher than those of the Mafb f/f mice (Fig. 1D,E) . Food consumption did not differ between the groups (Fig. 1C,F) . Moreover, when fed a normal diet, we found that the body weights of the Mafb ( Fig. 1G-I) . Taken together, these data suggest that MafB deficiency accelerates weight gain in mice.
MafB affects fat storage in mice
Next, we used CT scanning to measure fat storage ( Fig. 2A,B, upper panels) . The CT transaxial images showed that the Mafb À/À and Mafb f/f ::Tie2-Cre mice both had higher body fat accumulations (yellow parts) than the control mice ( Fig. 2A,B, lower panels) . Furthermore, the whole body fat percentages of the Mafb À/À and Mafb f/f ::Tie2-Cre mice were also higher than those of control mice (Fig. 2C,D) . In addition, we collected epididymal fat pads from the wild-type and Mafb À/À mice and inguinal and ovary fat pads from the Mafb f/f and Mafb f/f ::Tie2-Cre mice and measured the fat pad weights. The data showed that the epididymal fad pads from the Mafb À/À mice tended to have higher weights than those of the wild-type mice (Fig. 2E) . The Mafb f/f ::Tie2-Cre mice had significantly heavier inguinal and ovary fat pads than the Mafb f/f mice (Fig. 2F,G) . We also performed HE staining and measured adipocyte sizes. The Mafb-deficient mice had larger adipocytes than the wild-type mice (Fig. 3A,B) .
The Mafb f/f ::Tie2-Cre mice had larger adipocytes than the Mafb f/f mice (Fig. 3C,D) . Moreover, the Mafb f/f :: Tie2-Cre mice had higher serum cholesterol levels than the Mafb f/f mice in both the normal diet and HFD groups (Fig. 3E) . These data indicate that MafB deficiency increases the fat storage and serum cholesterol levels in mice. Because both of the evaluated Mafb-deficient lines (Mafb f/f ::Tie2-Cre and mice reconstituted with Mafb À/À fetal liver cells) showed a lack of MafB in hematopoietic cells only, we hypothesized that the presence of MafB in hematopoietic cells, such as macrophages, is responsible for adipose tissue mass.
MafB deficiency reduces AIM expression in adipose tissue macrophages
Previous reports have shown that ATMs are associated with development of obesity [20] [21] [22] . Because MafB plays an important role in the development and functioning of macrophages [5, 9] , we characterized Mafb expression in ATMs. We collected fat pads from mice of each genotype and made frozen sections. Then adipose sections were stained with anti-MafB antibody and anti-Mac-2 antibody, which has been previously reported to be expressed in ATMs [23, 24] . The data showed that MafB expression was detected in Mac-2 positive Mafb f/f macrophages which indicated MafB is expressed in adipose tissue macrophages (Fig. 4A) . In contrast, signals of MafB are not detected in Mafb f/f :: Tie2-Cre mice. Moreover, we examined immunostaining using anti-GFP antibody and anti-Mac-2 antibody. GFP gene was inserted into Mafb locus in Mafb-deficient mice [5] . The GFP expression derived by Mafb gene promoter was detected in Mac-2-positive macrophages (Fig. 4B) , implying a functional role of MafB in ATMs.
It has been previously reported that AIM-deficient mice exhibit increased adipocyte size and body fat weight when fed a HFD [16, 25] . We have previously demonstrated that MafB directly regulates AIM expression in foam cells in atherosclerosis [9] . Therefore, we investigated AIM expression in Mafb À/À macrophages. We found that both Mafb and AIM expression were significantly decreased in Mafb f/f :: Tie2-Cre mice relative to Mafb f/f mice (Fig. 4C) . These results indicate that reducing the expression of AIM in Mafb-deficient ATMs might affect adipose tissue mass and induce obesity.
Discussion
In this study, we first demonstrated that MafB deficiency in the hematopoietic system accelerates weight gain, enhances the body fat storage, and increases the adipocyte size. In adipose tissue, the reduction in AIM expression was observed in Mafb-deficient mice (Fig. 4C) . As the AIM promoter region contains a MARE and MafB binds to this site in macrophage within atherosclerosis lesion [9] , it is possible that MafB directly regulates AIM expression in ATMs. Recent studies have shown that AIM is also important for inhibiting obesity-related autoimmunity and steatosis-associated hepatocellular carcinoma tumor development [26, 27] . Further analysis is required to determine whether MafB regulates AIM expression in these cases.
Our previous study showed human MAFB and AIM were coexpressed in atherosclerosis lesion of patient [9] . In addition, a recent study showed that human MAFB is expressed in ATMs and MAFB expression correlates negatively with lipogenesis and lipolysis in human adipocytes [28] . These evidence suggest that MAFB may regulate AIM expression in human ATMs because AIM also inhibits fatty acid synthase activity of adipocyte [16] . Both in human and mouse, MafB is regulated by nuclear receptor transcription family such as liver x receptor (LXR), retinoic acid receptor (RAR), or retinoid x receptor (RXR) in monocytes/macrophages [9, 29] . Especially, LXR regulates AIM through MafB regulation in macrophage within atherosclerosis lesion [9] . Further analysis is required to find which pathway induces MafB expression in ATMs.
Overall, we showed that Mafb-deficient mice revealed an obesity phenotype. These mice might be useful as models in the investigation of new treatments for obesity.
